T. Rowe Price Associates
EW icon

T. Rowe Price Associates’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$67.3M Buy
860,092
+398
+0% +$31.1K 0.01% 655
2025
Q1
$62.3M Sell
859,694
-2,438,028
-74% -$177M 0.01% 655
2024
Q4
$244M Sell
3,297,722
-244,061
-7% -$18.1M 0.03% 386
2024
Q3
$234M Sell
3,541,783
-3,793,955
-52% -$250M 0.03% 407
2024
Q2
$678M Buy
7,335,738
+819,478
+13% +$75.7M 0.08% 213
2024
Q1
$623M Buy
6,516,260
+2,390,137
+58% +$228M 0.08% 239
2023
Q4
$315M Buy
4,126,123
+842,848
+26% +$64.3M 0.04% 331
2023
Q3
$227M Buy
3,283,275
+2,469,870
+304% +$171M 0.03% 365
2023
Q2
$76.7M Sell
813,405
-18,108
-2% -$1.71M 0.01% 583
2023
Q1
$68.8M Buy
831,513
+21,079
+3% +$1.74M 0.01% 597
2022
Q4
$60.5M Buy
810,434
+3,968
+0.5% +$296K 0.01% 615
2022
Q3
$66.6M Sell
806,466
-448
-0.1% -$37K 0.01% 573
2022
Q2
$76.7M Sell
806,914
-83,655
-9% -$7.95M 0.01% 739
2022
Q1
$105M Sell
890,569
-54,134
-6% -$6.37M 0.01% 718
2021
Q4
$122M Sell
944,703
-30,418
-3% -$3.94M 0.01% 705
2021
Q3
$110M Sell
975,121
-15,517
-2% -$1.76M 0.01% 733
2021
Q2
$103M Sell
990,638
-10,757
-1% -$1.11M 0.01% 773
2021
Q1
$83.8M Sell
1,001,395
-78,254
-7% -$6.55M 0.01% 825
2020
Q4
$98.5M Sell
1,079,649
-128,172
-11% -$11.7M 0.01% 727
2020
Q3
$96.4M Buy
1,207,821
+25,864
+2% +$2.06M 0.01% 665
2020
Q2
$81.7M Buy
1,181,957
+756,193
+178% +$52.3M 0.01% 693
2020
Q1
$80.3M Buy
425,764
+35,298
+9% +$6.66M 0.01% 639
2019
Q4
$91.1M Sell
390,466
-6,236
-2% -$1.45M 0.01% 694
2019
Q3
$87.2M Buy
396,702
+7,957
+2% +$1.75M 0.01% 660
2019
Q2
$71.8M Sell
388,745
-347
-0.1% -$64.1K 0.01% 755
2019
Q1
$74.4M Buy
389,092
+23,075
+6% +$4.41M 0.01% 721
2018
Q4
$56.1M Buy
366,017
+5,569
+2% +$853K 0.01% 781
2018
Q3
$62.8M Sell
360,448
-10,122
-3% -$1.76M 0.01% 828
2018
Q2
$53.9M Buy
370,570
+1,622
+0.4% +$236K 0.01% 871
2018
Q1
$51.5M Buy
368,948
+1,300
+0.4% +$181K 0.01% 857
2017
Q4
$41.4M Sell
367,648
-2,100
-0.6% -$237K 0.01% 930
2017
Q3
$40.4M Sell
369,748
-22,548
-6% -$2.46M 0.01% 931
2017
Q2
$46.4M Sell
392,296
-14,988
-4% -$1.77M 0.01% 849
2017
Q1
$38.3M Sell
407,284
-3,181
-0.8% -$299K 0.01% 905
2016
Q4
$38.5M Buy
410,465
+13,175
+3% +$1.23M 0.01% 903
2016
Q3
$47.9M Sell
397,290
-222,150
-36% -$26.8M 0.01% 820
2016
Q2
$61.8M Buy
619,440
+11,380
+2% +$1.13M 0.01% 702
2016
Q1
$53.6M Sell
608,060
-1,290
-0.2% -$114K 0.01% 745
2015
Q4
$48.1M Buy
609,350
+304,425
+100% +$24M 0.01% 778
2015
Q3
$43.4M Sell
304,925
-600
-0.2% -$85.3K 0.01% 816
2015
Q2
$43.5M Buy
305,525
+2,490
+0.8% +$355K 0.01% 889
2015
Q1
$43.2M Buy
303,035
+11,200
+4% +$1.6M 0.01% 889
2014
Q4
$37.2M Buy
291,835
+6,310
+2% +$804K 0.01% 936
2014
Q3
$29.2M Buy
285,525
+1,700
+0.6% +$174K 0.01% 1012
2014
Q2
$24.4M Sell
283,825
-8,090
-3% -$694K 0.01% 1062
2014
Q1
$21.7M Sell
291,915
-60,020
-17% -$4.45M ﹤0.01% 1084
2013
Q4
$23.1M Sell
351,935
-81,660
-19% -$5.37M 0.01% 1062
2013
Q3
$30.2M Sell
433,595
-7,563,781
-95% -$527M 0.01% 975
2013
Q2
$537M Buy
+7,997,376
New +$537M 0.14% 185